Article Text

Reminder of important clinical lesson
Pharmacological hyperprolactinaemia
  1. Maithili Srikantha,
  2. Richard Butterworth
  1. Milton Keynes Hospital NHS Foundation Trust, Department of Medicine, Standing Way, Eaglestone, Milton Keynes, Buckinghamshire, MK6 5LD, UK
  1. Maithili Srikantha, maithili.srikantha{at}gmail.com

Summary

A middle-aged woman was referred under the 2-week urgent brain cancer initiative following the finding of a raised serum prolactin level. The patient had been taking metoclopramide on a daily basis to aid her symptoms of irritable bowel syndrome. The raised prolactin level had led to oligomenorrhoea prompting her general practitioner (GP) to check pituitary hormone levels.

Metoclopramide is a potent dopamine antagonist and dopamine acts as the physiological inhibitor of prolactin synthesis. Thus, the dopamine antagonism led to elevated prolactin level and the symptom of oligomenorrhoea.

Following curtailment of the metoclopramide, the prolactin level normalised very quickly and the patient was reassured.

Consideration should be given to non-pathological causes of hyperprolactinaemia, including physiological states such as pregnancy and concurrent medication.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Competing interests: None.

  • Patient consent: Patient/guardian consent was obtained for publication.